An evaluation of a once daily dosage régime of dothiepin hydrochloride (prothiaden).
This paper reports on the use of a single daily dose of dothiepin hydrochloride (Prothiaden). The results from a metabolism study using [14C] dothiepin were used to calculate the daily variations in blood levels after once daily and thrice daily dose regimes. A clinical study on the use of a single daily dose of 75 mg of dothiepin showed this type of regime to be well tolerated and efficacious in the treatment of 105 depressed patients in general practice. Compared to a thrice daily regime the once daily dose appeared to be more beneficial on symptomatic insomnia during the early treatment period.
D000328:Adult; D003863:Depression / Q000188:drug therapy*; D003988:Dibenzothiepins / Q000008:administration & dosage*; D004308:Dothiepin / Q000008:administration & dosage* / Q000009:adverse effects / Q000378:metabolism; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012890:Sleep / Q000187:drug effects; D014987:Xerostomia / Q000139:chemically induced
D003988:Dibenzothiepins; D004308:Dothiepin